戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y collected clinical specimens (for example, core needle biopsies).
2 sy of 43% (181 true-positive findings of 419 core-needle biopsies).
3 nding of diagnostic techniques, particularly core needle biopsy.
4 ally as atypical ductal hyperplasia (ADH) by core needle biopsy.
5 neumothorax in patients undergoing CT-guided core needle biopsy.
6 mplications in patients undergoing CT-guided core needle biopsy.
7 aling malignant changes in the vicinity of a core needle biopsy.
8 y of nucleic acid yields from imaging-guided core needle biopsy.
9  without metastatic disease and diagnosed by core needle biopsy.
10 %) patients, open biopsy was performed after core-needle biopsy.
11 e the reliability of diagnoses obtained with core-needle biopsy.
12               To assess the complications of core-needle biopsy.
13 ith 43 benign papillary lesions diagnosed at core-needle biopsy.
14 rformed on tissue obtained with image-guided core-needle biopsy.
15 scopic findings at the time of lumpectomy or core-needle biopsy.
16 easibility of this assay for analyzing small core needle biopsies.
17 tions with limited sample quantities such as core needle biopsies.
18 ncreatic tumors from resection specimens and core needle biopsies.
19 y indicated, ultrasound-guided, percutaneous core needle biopsies.
20 ter numbers of viable cells when compared to core needle biopsies.
21 ing is largely dependent upon examination of core-needle biopsies.
22                              After US-guided core-needle biopsy, 115 (58%) of 198 patients were treat
23                     Twenty-four studies used core-needle biopsy; 44, vacuum-assisted biopsy; 21, both
24 ) compared with those with ADH diagnosed via core needle biopsy (5%; 95% CI, 2.2%-8.9%).
25 agnostic yield (71.5% [40/56]) compared with core-needle biopsy (50% [17/34] P = .04) and fine needle
26 were almost three times as high as those for core-needle biopsy ($698 vs $243).
27             Among 572 scheduled stereotactic core-needle biopsies, 89 cases (16%) in 88 patients were
28  CT-guided transsternal approach for coaxial core-needle biopsy allows safe access to masses in vario
29  human tissue sample manufacturing including core needle biopsy and minimal ascites samples.
30 , or high-risk (for cancer) breast tissue at core-needle biopsy and had undergone subsequent surgery
31 c accuracy of other interventions, including core-needle biopsy and needle-localized open surgical bi
32 uracy of US-guided FNA is similar to that of core needle biopsy, and there were no complications in t
33 graphic findings, the histologic findings at core-needle biopsy, and the findings at subsequent surgi
34                         Definitive surgical, core-needle biopsy, and/or follow-up information was ava
35              Patients underwent pretreatment core needle biopsy; archival tumor samples were also obt
36 CT and OCM, which has the potential to guide core needle biopsies, assess surgical margins, and evalu
37 32 male, 192 female) who underwent CT-guided core needle biopsy between January 2021 and October 2022
38                                 Percutaneous core-needle biopsy can be an effective alternative to op
39                                     However, core needle biopsy (CNB) has become widely accepted as p
40 e compared with the Gleason score (GS) after core needle biopsy (CNB) in patients with low, medium an
41                                 Percutaneous core needle biopsy (CNB) is optimal for minimizing surge
42                                 Preoperative core needle biopsy (CNB) may cause lymph node capsule di
43 ns (FELs) are a common histologic finding on core needle biopsy (CNB) of the breast.
44 ne needle aspiration biopsy (FNA), and liver core needle biopsy (CNB) samples were collected from par
45                                              Core needle biopsy (CNB) sampling is known to be inexpen
46 h between breast lesions classified as B3 at core needle biopsy (CNB) that show or do not show atypia
47  of columnar cell lesions (CCLs) in a breast core needle biopsy (CNB).
48 ation biopsies (FNAB) controlled with CT and core-needle biopsy (CNB) under real-time CT fluoroscopy
49 chniques (mammography and US), confirmed via core-needle biopsy (CNB), and enrolled between March 201
50            Low-strength evidence showed that core-needle biopsies conducted under stereotactic guidan
51 lic and lipidomic profiles of routine breast core needle biopsies could be obtained effectively.
52                                 Stereotactic core needle biopsy decreases the cost of diagnosis, but
53                        Studies that compared core-needle biopsy diagnoses with open surgical diagnose
54      However, despite stereotactic guidance, core needle biopsy fails to retrieve microcalcifications
55 ogic findings in the surgical specimens when core-needle biopsy findings indicated malignancy or foll
56 he MR imaging-guided 9-gauge vacuum-assisted core-needle biopsy findings of 85 lesions in 75 patients
57 r at least one year; 76 (96.2%) had negative core-needle biopsy findings, and 74 (97.3%) of these rem
58          To determine the reliability of the core-needle biopsy findings, we compared the diagnosis f
59 avoiding lobectomies in patients with benign core-needle biopsy findings.
60 scape for spectroscopic validation of breast core needle biopsy for detection of microcalcifications
61 wed 101 patients who underwent transthoracic core needle biopsy for the KEYNOTE-001 (MK-3475) clinica
62 re collected from women who underwent breast core-needle biopsy for calcifications that was performed
63 nderwent percutaneous CT-guided coaxial lung core-needle biopsy for suspected primary lung cancer bet
64                           The sensitivity of core-needle biopsy for the diagnosis of thyroid cancer w
65 ide expression profiling was performed on 50 core needle biopsies from 18 breast cancer patients usin
66               As a demonstration, we analyze core needle biopsies from ERBB2 positive breast cancers
67 ls that coexpress E-cadherin and vimentin in core-needle biopsies from patients with various advanced
68 ]Ga-ABY-025 PET/CT, [(18)F]F-FDG PET/CT, and core-needle biopsies from targeted lesions were performe
69 es from diagnostic tumor biopsies, including core-needle biopsies frozen in a non-viable format, to e
70                                       First, core needle biopsies generate little tissue material, an
71                       Multisite stereotactic core needle biopsy had a positive effect on patient care
72 in imaging and medical technology, CT-guided core needle biopsy has largely replaced fluoroscopic-gui
73        Twenty-two pre-operative Image Guided Core Needle Biopsies (IGCNB) were performed.
74 vity, specificity, and accuracy of US-guided core needle biopsy in differentiating benign from malign
75        This retrospective study reviewed 195 core-needle biopsies in 178 patients.
76                                              Core-needle biopsy in comparison to fine-needle aspirati
77 he sensitivity, specificity, and accuracy of core-needle biopsy in the detection of malignant neoplas
78  to 2012, the proportion of ADH diagnosed by core needle biopsy increased from 21% to 77%.
79                                              Core needle biopsy increases patient satisfaction and re
80        Conclusion Image-guided transthoracic core needle biopsy is an effective method for obtaining
81                       Multisite stereotactic core needle biopsy is feasible, safe, and may influence
82                                 Stereotactic core needle biopsy is the diagnostic procedure of choice
83       Background Percutaneous CT-guided lung core-needle biopsy is a frequently performed and general
84 ast lesions is necessary before stereotactic core-needle biopsy is scheduled.
85                                        Large-core needle biopsy (LCNB) has become an alternative to s
86     Stereotactic, 14-gauge, automated, large-core needle biopsy (LCNB) was performed in 483 consecuti
87                                           At core-needle biopsy, lesions were diagnosed as papilloma
88                         At MR imaging-guided core-needle biopsy, malignancy was identified in 52 (61%
89 of metallic clips placed during stereotactic core-needle biopsy may differ substantially from the loc
90 th fine-needle aspiration (n = 55), 14-gauge core-needle biopsy (n = 81), or both (n = 14).
91                          Tissue collected by core needle biopsy of a left internal jugular lymph node
92 atus in recurrent disease is usually made by core needle biopsy of a single lesion, which may not rep
93 dy (59.4%) would not make it safe to avoid a core needle biopsy of lesions that undergo contrast enha
94  Twenty-five patients underwent stereotactic core needle biopsy of more than one site.
95                            Ultrasound-guided core needle biopsy of the breast mass diagnoses an invas
96 iphering the impact of invasive percutaneous core needle biopsy of the kidney allograft on diagnostic
97                  Findings at 209 consecutive core-needle biopsies of lesions of the thyroid gland in
98 /METHODS: From January, 2012 to May 2013, 76 core-needle biopsies of lung and mediastinum tumors were
99 d needle track created by stereotactic large-core-needle biopsy of the breast.
100 rly selected cases by those performing large-core-needle biopsy of the breast.
101                                              Core-needle biopsy of the renal cortex obtained during s
102                                    US-guided core-needle biopsy of the thyroid gland is a safe outpat
103                                              Core-needle biopsy of thyroid nodules is effective becau
104                          Diagnosis of ADH on core needle biopsy or excisional biopsy in women undergo
105 e needle aspiration and tissues obtained via core needle biopsy or surgery.
106 gh risk for breast cancer and should undergo core-needle biopsy or needle localization with surgical
107 ances in diagnostic techniques, specifically core needle biopsies performed under mammographic and ul
108  on radiographs of the specimens obtained at core needle biopsy performed through the region of color
109 st lesion, in real-time, during stereotactic core needle biopsy procedures.
110     Stereotactic- and ultrasonography-guided core-needle biopsy procedures seem to be almost as accur
111                       In 105 (74%) patients, core-needle biopsy results were concordant with results
112             In 36 (26%) patients, inaccurate core-needle biopsy results were obtained: In nine, resul
113                            Ultrasound-guided core needle biopsy revealed an infiltrating ductal carci
114 ing (MITS), a postmortem procedure that uses core needle biopsy samples and does not require opening
115                       Overall mean number of core needle biopsy samples obtained was 7.9 samples.
116 ul for regular quantification of steroids in core needle biopsy samples of breast tissue to inform do
117 indings were compared with histopathology of core needle biopsy samples or with ultrasound follow-up
118 to whole sections, paired surgical resection/core needle biopsy samples, and paired samples from 69 p
119 psy techniques include stereotactic 14-gauge core-needle biopsy (SC bx), stereotactic 11-gauge suctio
120 aluated the differences between stereotactic core needle biopsy (SCNBx) and needle localization surgi
121 hat papillary lesions diagnosed as benign at core-needle biopsy should be surgically excised because
122                                        Large-core needle biopsy showed diffuse calcifications within
123       The isolation of glomerular cells from core needle biopsy specimens for single-cell transcripto
124 cells; however, the efficacy of snRNA-seq on core needle biopsy specimens remains to be proven.
125           Formalin-fixed human breast cancer core-needle biopsy specimens, were embedded, lipid-clear
126 s is reached by the histological analysis of core-needle biopsy specimens.
127 Needle Aspiration, Thorax, CT, Pneumothorax, Core Needle Biopsy, Texture Analysis, Radiomics, CT Supp
128  risk for severe complications is lower with core-needle biopsy than with open surgical procedures (<
129 hic lesions entirely removed at percutaneous core needle biopsy that required wider excision underwen
130 confirmed by computed tomography (CT)-guided core needle biopsy that was performed 2-4 weeks before c
131 ples and 177 tissue samples (ie, resected or core-needle biopsied tissues).
132 ogic findings, fibrin bands or collagen, and core needle biopsy tract at microscopy.
133  to the great increase in the utilization of core needle biopsies under mammographic and ultrasonogra
134 mizing nucleic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there sh
135                 Cost savings of stereotactic core needle biopsy vary in subgroups of patients defined
136 e cancer associated with ADH diagnosed using core needle biopsy vs excisional biopsy.
137 uly 1992 through February 1995, stereotactic core needle biopsy was performed in 356 women with 405 n
138                                              Core-needle biopsy was performed at a tertiary care inst
139 mmography, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive dia
140                For each lesion, image-guided core-needle biopsy was performed immediately after PET m
141 vity, specificity, and accuracy of US-guided core-needle biopsy were calculated.
142 hom breast cancer was initially diagnosed by core-needle biopsy were more likely than women with canc
143                 Five patients also underwent core-needle biopsy with a coaxially introduced 20-gauge
144                  One hundred eleven cases of core-needle biopsy with clip deployment were reviewed.
145  believe that biopsy procedures - especially core needle biopsies - with CEUS assistance are potent t
146 d ratio (HR) of 3.0 (95% CI, 2-4.5) and, via core needle biopsy, with an adjusted HR of 2.2 (95% CI,
147                                              Core-needle biopsy yielded a diagnosis for 179 (91.7%) n

 
Page Top